Viewing Study NCT01733758


Ignite Creation Date: 2025-12-25 @ 12:03 AM
Ignite Modification Date: 2026-06-17 @ 5:17 PM
Study NCT ID: NCT01733758
Status: COMPLETED
Last Update Posted: 2016-09-22
First Post: 2012-11-21
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Monotherapy Study to Evaluate the Efficacy and Safety of 2 Dose Levels of Albiglutide in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM)
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetes Mellitus, Type 2 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None albiglutide View
None Japanese View
None GSK716155 View
None Type 2 diabetes mellitus View
None glucagon-like peptide 1 View